Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Cytori Therapeutics, a regenerative medicine company, has closed and received net proceeds from the definitive agreements the company entered into recently to raise $10 million, before placement agent fees and offering expenses.
Subscribe to our email newsletter
Cytori offered the securities in this transaction pursuant to an effective shelf registration statement.
The funds will be used for sales and marketing activities related to the commercialization of the Celution system and consumables as well as other related and complementary products, for ongoing clinical studies of the Celution system for breast reconstruction and cardiovascular disease, for ongoing R&D to support the company’s products and its pipeline development, and for general working capital.